Of note, non‐small cell lung cancer is often associated with an improved prognosis in patients with positive driver gene mutations, such as epidermal growth factor receptor (EGFR) mutation and EML4‐ALK gene mutation.4, 15. The gene discussed is ALK; the disease is lung cancer.